SCMP News Alert Sucampo Pharmaceuticals (SCMP) 13.75 12/25/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Sucampo Pharmaceuticals (SCMP) 13.75 $SCMP

Keryx (KERX) Launches Renal Drug Auryxia in the U.S. - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 3:35PM CST
Keryx Biopharmaceuticals, Inc. (KERX) announced it has begun to ship Auryxia (ferric citrate) tablets to wholesalers in the U.S.
AGN: 210.12 (+0.95), SHPG: 209.29 (+0.07), SCMP: 13.75 (+0.44), KERX: 14.00 (+0.20)

Gilead/Ono Pharmaceutical Ink Deal for Blood Cancer Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 22, 3:12PM CST
Gilead Sciences, Inc. and Ono Pharmaceutical Co., Ltd. announced that they have entered into an agreement for ONO-4059.
VRX: 140.33 (-0.22), GILD: 91.29 (+1.84), SCMP: 13.75 (+0.44)

Emergent BioSolutions Buys EV-035 Series from Evolva - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 18, 3:45PM CST
Emergent BioSolutions Inc. announced that it has entered into an agreement with Evolva Holding for acquiring the latter's anti-bacterial program.
ACT: 254.20 (-1.68), VRX: 140.33 (-0.22), EBS: 27.64 (+1.28), SCMP: 13.75 (+0.44)

UCB's Kremers Urban Sale Deal Lapses, Divestiture Plan On - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 18, 2:20PM CST
UCB (UCBJF), Advent International and Avista Capital Partners announced their decision to mutually terminate their deal for the acquisition of UCB's Kremers Urban.
LCI: 42.29 (+1.79), VRX: 140.33 (-0.22), SCMP: 13.75 (+0.44)

Uptrend Call Working As Sucampo Pharmaceuticals Stock Rises 92.8% (SCMP)
Comtex SmarTrend(R) - Thu Dec 18, 9:35AM CST
SmarTrend identified an Uptrend for Sucampo Pharmaceuticals (NASDAQ:SCMP) on August 13th, 2014 at $6.98. In approximately 4 months, Sucampo Pharmaceuticals has returned 92.84% as of today's recent price of $13.46.
SCMP: 13.75 (+0.44)

Cyclacel Falls on Poor Acute Myeloid Leukemia Drug Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 17, 4:00PM CST
In the SEAMLESS study on sapacitabine, the DSMB found that the planned futility boundary has been crossed.
ACT: 254.20 (-1.68), VRX: 140.33 (-0.22), CYCC: 0.69 (+0.01), SCMP: 13.75 (+0.44)

Salix Gains on Destocking Initiatives, Gives 2-Year Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 17, 1:12PM CST
Salix (SLXP) expects to resolve its inventory situation a year ahead of schedule and now expects a FDA response on Xifaxan 550 by May 27, 2015.
LCI: 42.29 (+1.79), SCMP: 13.75 (+0.44), SLXP: 114.92 (-1.18), BIOD: 1.36 (-0.04)

Alexion Announces New Share Repurchase Program of $500M - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 5:55PM CST
Alexion Pharmaceuticals, Inc. (ALXN) announced that a new share repurchase program of up to $500 million have been authorized by its board of directors.
ACT: 254.20 (-1.68), VRX: 140.33 (-0.22), SCMP: 13.75 (+0.44), ALXN: 181.96 (+3.09)

Sophiris Plunges on Disappointing Data on its BPH Candidate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 3:30PM CST
Sophiris Bio Inc.'s (SPHS) shares plummeted 81.5% after the company announced disappointing data from an interim efficacy analysis of its ongoing phase III study on PRX302.
ACT: 254.20 (-1.68), VRX: 140.33 (-0.22), SPHS: 0.46 (+0.02), SCMP: 13.75 (+0.44)

Calithera Biosciences Slumps: CALA Tanks 10.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 7:50AM CST
Calithera Biosciences (CALA) fell by over 10% in the last trading session amid huge volumes, reversing its recent uptrend, as the stock is now up nearly 185% in the past one month.
LCI: 42.29 (+1.79), SCMP: 13.75 (+0.44), CALA: 22.33 (+1.16), IG: 9.11 (-0.01)

Sucampo names John H. Johnson to board
M2 - Tue Dec 16, 6:04AM CST
Biopharmaceutical company Sucampo Pharmaceuticals (NasdaqGM:SCMP)revealed on Monday the election of John H. Johnson to its board of directors.
PTLA: 28.35 (+0.21), SCMP: 13.75 (+0.44)

One Stock Chart Trick You Should All Know - Investment Ideas
David Bartosiak - ZACKS - Tue Dec 16, 12:00AM CST
One Stock Chart Trick You Should All Know - Investment Ideas
HSKA: 18.13 (+0.24), ANIP: 55.24 (+1.79), SCMP: 13.75 (+0.44)

ChemoCentryx Up on Positive Diabetic Nephropathy Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 15, 5:45PM CST
ChemoCentryx, Inc., announced positive top-line 52-week data from its phase II study on its candidate CCX140 for diabetic nephropathy.
ACT: 254.20 (-1.68), VRX: 140.33 (-0.22), SCMP: 13.75 (+0.44), CCXI: 6.64 (-0.04)

Astellas-Medivation Reveal Data on Xtandi for Breast Cancer - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 15, 2:00PM CST
Astellas Pharma Inc. (ALPMY) and Medivation announced the presentation of stage I and preliminary stage II data from a phase II study on Xtandi triple negative breast cancer.
MDVN: 99.23 (+1.23), LCI: 42.29 (+1.79), SCMP: 13.75 (+0.44)

Cerulean Pharma (CERU) Worth Watching: Stock Rises 16.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 15, 8:39AM CST
Cerulean Pharma Inc. (CERU) was a big mover last session, as its shares rose over 16% on the day.
LCI: 42.29 (+1.79), CERU: 6.45 (unch), SCMP: 13.75 (+0.44), IG: 9.11 (-0.01)

Flexion Therapeutics (FLXN) Worth Watching: Stock Up 9.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 15, 8:25AM CST
Flexion Therapeutics (FLXN) was a big mover last session, with shares rising over 9% on the day.
LCI: 42.29 (+1.79), FLXN: 20.56 (+0.02), SCMP: 13.75 (+0.44), IG: 9.11 (-0.01)

ChemoCentryx (CCXI) Shows Strength: Stock Moves Up 24.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 15, 7:51AM CST
ChemoCentryx, Inc. (CCXI) was a big mover last session, as its shares rose almost 25% on the day.
LCI: 42.29 (+1.79), SCMP: 13.75 (+0.44), CCXI: 6.64 (-0.04), IG: 9.11 (-0.01)

Sucampo Appoints John H. Johnson to Board of Directors
GlobeNewswire - Mon Dec 15, 5:45AM CST
Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced the appointment of John H. Johnson, founder, Plum Brook Advisors, to its board of directors (Board).
SCMP: 13.75 (+0.44)

What Falling Estimates & Price Mean for Immune Design Corp. (IMDZ) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Dec 12, 7:39AM CST
One stock that you may want to consider dropping is Immune Design Corp. (IMDZ), which has witnessed a significant price decline in the past four weeks
LCI: 42.29 (+1.79), IMDZ: 34.96 (+0.78), SCMP: 13.75 (+0.44), IG: 9.11 (-0.01)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

VIGGO’s Mix1Pro Tests Practical Commercial Cleaning

Updated Category News Views 81

A cleaning robot earns its keep in the ugly corners, not under convention-center lights. VIGGO used the ISSA Show North America gathering in Las Vegas, held November 17–19, 2026, to introduce the Mix1Pro, a compact commercial machine aimed at indoor facilities below 53,800 square feet. That target matters. Smaller, messier sites are where autonomy can look terrific on a...

Continue Reading
Why Dent Repair Estimates Need More Than a Simple Ruler

Updated Category News Views 118

A dent can look harmless in a parking-lot glare and still turn into a stubborn repair job once somebody examines the metal properly. That is the useful, unglamorous point Jason Phelps of Magic Dent makes in a HelloNation article: visible diameter is not a verdict. Anybody shopping for vehicle repairs, managing fleet costs, or watching the collision-service ecosystem ought...

Continue Reading
SHEIN's EU Training Push Targets Seller Compliance Gaps

Updated Category News Views 102

Chemicals buried in a cheap handbag or kids' accessory can wreck a marketplace's credibility faster than any glossy campaign can repair it. That is the uncomfortable backdrop to SHEIN and SPEAC's November 19 session on EU chemical-safety rules for marketplace sellers. This was not a fashion trend webinar; it was a practical warning about high-risk substances, regulatory...

Continue Reading
Delayed Remodels Can Quietly Drain Your Home's Value

Updated Category News Views 51

A pinhole leak has a nasty talent for becoming a demolition budget. That is the plain lesson in Jason Marks' discussion of delayed remodeling for homeowners in Kernersville, North Carolina. People tend to see a worn bathroom, tired kitchen, or drafty window and think, “Not pretty, but it can wait.” Sometimes it can. Sometimes that little delay lets water, rot,...

Continue Reading
Foresight Solar Insurance Trial Beats Fixed PPA Route

Updated Category News Views 107

Six solar sites and one settled insurance contract have produced a result worth studying, not celebrating with confetti. Foresight and Paratus say their completed renewable-price insurance policy generated a £14.49/MWh net uplift, after premium, against the revenue those assets would have earned under a fixed-price power purchase agreement. In a UK renewables market...

Continue Reading
Workers Are Burning Savings as Pay Falls Behind Costs

Updated Category News Views 69

Payroll optimism has been ground into dust by the ordinary bills nobody can dodge. Monster's 2026 Cost of Living Report says 93% of employed U.S. workers feel their wages are failing to keep up with costs, barely different from 95% in both 2024 and 2025. That is not a blip, and it is not workers merely grousing about prices. Three years of nearly identical frustration...

Continue Reading
Webster First Takes Aim at the Youth Money Literacy Gap

Updated Category News Views 86

Money mistakes get expensive long before anyone calls them mistakes. That is the uncomfortable point beneath Webster First Federal Credit Union CEO John Thomasian's November 20, 2026 discussion of financial literacy: plenty of young adults are entering the real financial world with a card, a loan offer, and a phone full of banking apps, but no sturdy framework for using...

Continue Reading
Niron's $1.8B Alabama Bet Carries Big Magnet Stakes

Updated Category News Views 35

A Huge Factory Claim Needs More Than Applause A magnet company just tossed a very large number onto Alabama's economic-development table. Niron Magnetics says it plans a $1.8 billion investment in the state that would create 700 jobs. That is not pocket change, not a ribbon-cutting trinket, and not the sort of announcement investors should breeze past between earnings...

Continue Reading
Trade Secret Damages Turn on Corporate Intent Evidence

Updated Category News Views 101

Suspicion may rattle a courtroom, but it apparently does not always loosen the jury’s purse strings. That is the useful, slightly sobering takeaway from DOAR’s new national study on damages in trade secret disputes, released November 20, 2026. Jurors, according to the report, draw a meaningful line between an employee carrying experience to a new job and a company...

Continue Reading
GreenTree Faces Softer Rooms, Debt and NYSE Deadline

Updated Category News Views 34

A hotel operator can post positive earnings and still leave shareholders with a nasty headache, and GreenTree's third quarter is that kind of report. NYSE:GHG produced RMB243.0 million in revenue, down 22.2% from a year earlier, while net income slipped to RMB49.3 million from RMB59.0 million. This was not a one-line stumble. Room pricing, occupancy, franchise economics...

Continue Reading

Top 5 Most Recently Viewed Articles

NAL Research Unveils Innovative Tracking Solutions with Iridium

Updated Category News Views 188

NAL Research Integrates Iridium’s Enhanced SBD Service NAL Research, a leader in wireless communication solutions, is excited to announce the incorporation of Iridium's Enhanced Short Burst Data (ESBD) service into its renowned SHOUT product line. This advancement is set to significantly enhance communications security and performance, particularly for users in...

Continue Reading
International Perspectives on China's Growth: A Global Survey Insight

Updated Category News Views 262

Understanding Global Confidence in China's Development As change sweeps across the globe, the perception of China's trajectory is capturing increasing international attention. A recent survey conducted by the Global Times, which engaged over 51,300 respondents from various nations, uncovers valuable insights on how the world views China's growth and development. This...

Continue Reading
SKF Q3 2026: Margins Edge Up Amid Strategic Shifts

Updated Category News Views 192

Cracking Open SKF's Latest Quarterly Numbers Ever seen a company limber up for a big change while tiptoeing through a minefield? That’s SKF for you in this third quarter ending September 2026. Imagine them trying to juggle a spinning platter of growth, strategic separation, and robust margins, all while balancing a wobbly market. A Close Look at Q3's Financial Feats...

Continue Reading
California Oil Refiners' Profits Hit $1.24/Gallon in April

Updated Category News Views 95

California's Refiners Cashing in Big at the Pump Look, when you see profit margins jumping from 49 cents to $1.24 per gallon within a few months, you know the game in California's oil market is something to keep your eye on. The California Energy Commission (CEC) just tossed us a bone with their recent data drop, and it paints a picture of a market with exploding margins,...

Continue Reading
Explore the Growth of Coeur Mining Stock Over a Decade

Updated Category News Views 139

Coeur Mining's Investment Journey Over the Last Decade Coeur Mining Inc (NYSE: CDE) has truly distinguished itself over the past decade, demonstrating a commendable performance that has exceeded market expectations. With an annualized return surpassing the market by 7.64%, investors have seen an impressive average annual return of 20.17%. Today, Coeur Mining boasts a...

Continue Reading